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Background: The utility of intra-aneurysmal pressure determination is dependent on the ability to measure pressure
in the presence of endoleak and thrombosis. In this study, the accuracy of a CardioMEMS wireless pressure sensor
(CardioMEMS, Atlanta, Ga) transducer in the presence of thrombus associated with type II endoleak was measured.
Methods: Type II endoleaks were created in four mongrel dogs by implanting four collateral arterial side branches (lumbar
and caudal mesenteric arteries) as a Carrel patch onto a 3-cm prosthetic polytetrafluoroethylene abdominal aortic
aneurysm (AAA). The aneurysm was excluded 2 weeks later from antegrade perfusion by a stent graft. The wireless
pressure sensor was positioned in the AAA external to the stent graft. A Konigsberg intraluminal solid-state strain-gauge
pressure transducer (Konigsberg Instruments, Pasadena, Calif) that is accurate in the presence of thrombus served as the
control to determine AAA pressure. Both of the transducers were implanted on the luminal surface of the aneurysm, 180
degrees opposite from the Carrel patch and endoleak channel. Intra-aneurysmal pressure resulting from the type II
endoleak was measured twice daily for 4 weeks using both transducers. A total of 56 pre-exclusion and 224 post-exclusion
distinct pressure determinations were made. Intra-aneurysmal pressure was indexed to the systemic pressure that was
simultaneously measured by a strain-gauge pressure transducer implanted in the native aorta. Histologic analysis of the
aneurysm contents was performed with hematoxylin and eosin.
Results: The intra-aneurysmal systolic, mean, and pulse pressures produced by the type II endoleak were significantly
lower than systemic pressure in all animals and were<60% of systemic pressure (P< .001). Close correlation between the
wireless transducer and the control strain-gauge transducer was observed (R  0.83, P < .001). Arteriography and
Doppler ultrasound documented retrograde flow through the aneurysm side branches and persistent endoleak patency up
to the time of euthanasia. Pathologic analysis demonstrated the endoleak channel to be patent and separated from the
transducers by thrombus, which surrounded both transducers.
Conclusions: Intra-aneurysmal pressure generated by type II endoleaks may be accurately measured through thrombus
using a wireless pressure sensor in the canine model. The wireless sensor has the potential for clinical applicability in
diagnosing and characterizing type II endoleaks. ( J Vasc Surg 2006;44:1306-13.)
Clinical Relevance: Endoleaks originating from retrograde flow in the side branch vessels of the aneurysm generate
significant pulsatile pressurization of the aneurysm sac. Monitoring pressure by using a wireless sensor in the presence of
aneurysm sac thrombus may better define the clinical significance of endoleaks and may become a valuable tool for
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1306Endovascular treatment of abdominal aortic aneurysm
(AAA) is predicated on complete exclusion of the aneurysm
from the arterial circulation. Successful exclusion eliminates
systemic pressurization of the aneurysm sac and therefore
prevents continued aneurysm expansion and rupture. En-
doleak, which is the continued arterial perfusion of the
aneurysm sac after endovascular treatment, may compro-
mise the effectiveness of endovascular repair.1 Endoleaks
that originate from retrograde flow through collateral ves-
sels into aneurysm side branch arteries, or type II en-
doleaks, have been recently reported to occur in 6% to 17%
of patients in the perioperative period and have been noted
JOURNAL OF VASCULAR SURGERY
Volume 44, Number 6 Chaer et al 1307to remain patent in 1% to 5% of patients at 1 year of
follow-up.2 Although infrequently associated with aneu-
rysm rupture, they often result in significant pressurization
of the aneurysm sac in clinical and experimental settings.
The significance of endoleaks and their relationship to
aneurysm enlargement and rupture remain incompletely
understood and are a topic of debate. Several in vitro and
animal aneurysm models have attempted to characterize
the changes in aneurysm sac pressurization after endovas-
cular exclusion by using a strain-gauge solid-state pressure
transducer.3-11 Wireless sensors have also been used in
patients undergoing endovascular aneurysm repair to mea-
sure sac pressure postoperatively.12 However, the accuracy
of wireless transducers in the presence of intra-aneurysmal
thrombus and type II endoleaks has not been determined.
In previous studies, a canine model of chronic retro-
grade collateral (type II) endoleak has been developed.
Intra-aneurysmal pressure generated by the retrograde en-
doleak was determined using a solid-state strain-gauge
pressure transducer. In the current study, intra-aneurysmal
pressure obtained by using a wireless sensor was compared
with measurements made with the previously validated solid-
state strain-gauge pressure transducer. The current study also
sought to correlate the histologic findings of thrombus char-
acter and distribution with the intra-aneurysmal pressure
determinations. Retrograde endoleaks were therefore char-
acterized by the resultant intra-aneurysmal pressure and
intra-aneurysmal thrombus histology.
MATERIAL AND METHODS
Animals and implantation. Prosthetic aneurysms
were created in the infrarenal aortas of four male mongrel
dogs. All animals were treated in accordance with theGuide
for the Care and Use of Laboratory Animals formulated by
the Institute of Laboratory Animal Resources, Commission
on Life Sciences.13 The animals weighed between 25 and
Fig 1. Intraoperative photograph demonstrates the prosthetic
aneurysm and the reimplanted Carrel patch (double arrow). Pres-
sure transducer (Konigsberg) cables can be seen exiting the ante-
rior aspect of the aneurysm and the native aorta. The Cardio-
MEMS sensor was sewn onto the luminal aspect of the aneurysm
sac (arrow).30 kg.The details of the surgical procedure have been previ-
ously described.4,5 A prosthetic aneurysm containing two
intraluminal pressure transducers was implanted as an in-
terposition graft in the infrarenal aorta (Fig 1). The two
transducers were the CardioMEMSwireless pressure sensor
(CardioMEMS, Atlanta, Ga), and the Konigsberg strain-
gauge pressure transducer (Konigsberg Instruments, Pasa-
dena, Calif). Collateral side branch vessels (paired lumbar
arteries, caudal mesenteric) were reimplanted onto the
aneurysm with a Carrel patch technique (Fig 2).
The CardioMEMS was deployed ex vivo and was sewn
onto the prosthetic aneurysm before sterilization. The ca-
ble from the strain-gauge pressure transducer was tunneled
laterally through the abdominal wall and tracked subcuta-
neously to exit the skin on the posterior aspect of the neck.
Tomonitor systemic arterial pressure, a second implantable
pressure transducer was placed in the native aorta proximal
to the aneurysm and tunneled along a parallel course,
exiting the skin in the neck adjacent to the first transducer.
Measurements from all transducers were obtained si-
multaneously to enable comparison of intra-aneurysmal
pressure and systemic arterial pressure. The luminal trans-
ducers were implanted 180 degrees opposite from the
endoleak channel. Both transducers were used to measure
sac pressure resulting from the type II endoleak for 4 weeks.
Pressure transducers and prosthetic aneurysm
creation. Prosthetic aneurysms were created by balloon
dilation of an unaltered nonringed 8-mm Impra polytetra-
fluoroethylene (PTFE) conduit (Bard Corp, Murray Hill,
Fig 2. Schematic of retrograde (type II) endoleak creation. A
prosthetic aneurysm is sewn as an interposition graft in the infra-
renal aorta. Paired lumbar and caudal mesenteric arteries are reim-
planted onto the aneurysm as a Carrel patch (P). Konigsberg (K)
strain-gauge pressure transducer enables intra-aneurysmal and sys-
temic pressure determination. Wireless pressure CardioMEMS
sensor (C) allows simultaneous sac pressure determination. Retro-
grade (type II) endoleak is created by deploying a stent graft
coaxially through the aneurysm to exclude it from antegrade
perfusion.NJ) to a final aneurysm diameter of 30 mm. An implant-
surfa
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berg Instruments) was used for continuous in vivo moni-
toring of intra-aneurysmal pressure (Fig 3). The transducer
is highly accurate in measuring pressure in a wide range of
physiologic applications, including intracardiac, intracecal,
and intravascular thrombus. The accuracy of the transducer
has also been confirmed in various media in vitro, including
liquid, gelatinous, and solid environments.3,14 Calibration
of the transducer was performed before implantation and
after explantation.
Awireless sensor (CardioMEMSEndoSureWireless AAA
Pressure Measurement System) was also implanted in the
lumen of the aneurysm sac, opposite the Carrel patch and
adjacent to the strain-gauge pressure transducer (Fig 3). Both
transducers were approximated to the luminal surface of
the prosthetic aneurysm. The CardioMEMS Interrogator
cart antenna was used intraoperatively and postoperatively
to record sac pressure. The cart’s antenna transmits radio-
frequency energy to the sensor, charging the circuit inside
the sensor by the radiofrequency energy. The sensor then
returns a resonant frequency signal back to the antenna,
which is translated by the electronics into a pressure mea-
surement. Both transducers recorded systolic, diastolic,
mean, and pulse pressures.
Creation of a retrograde (type II) endoleak. After
implantation of the aneurysm containing the pressure
transducers and side-branch arteries, intra-aneurysmal pres-
sure determinations were made daily for 2 weeks. Exclusion
of the aneurysm sac from antegrade perfusion was then
performed with a covered stent (Viabahn endoprosthesis,
W. L. Gore & Assoc, Phoenix, Ariz). The details of the
Fig 3. A, A 3-mm implantable strain-gauge pressure tra
B, The CardioMEMS sensor was sewn onto the luminalaneurysm exclusion have been previously described.4,5 Thestents were 8 mm in diameter and 5 cm long, and two
prostheses were used per aneurysm exclusion and deployed
in an overlapping fashion through a 9F sheath. The stent
graft was implanted transarterially through femoral access.
Clopidogrel (75 mg/d) was administered to all animals 3
days before deployment of the endovascular stent graft to
enhance retrograde endoleak patency.
After stent graft deployment, intra-aneurysmal pressure
was determined continuously for 4 hours, then twice daily
for 4 weeks, until euthanasia of the animal. All animals were
euthanized 6 weeks after aneurysm implantation.
Systemic pressure was obtained simultaneously with a
second transducer implanted in the native infrarenal aorta.
The average systolic, diastolic, mean, and pulse intra-aneu-
rysmal pressures were indexed to the corresponding sys-
temic arterial pressure and were reported as a percentage of
systemic pressure. In addition, systemic pressure measure-
ments were confirmed with a forelimb sphygmomanometer
at the same setting.
Radiologic imaging. Radiologic evaluationwas used to
assess patency of the reimplanted aneurysm side branches and
endoleak. At endografting, arteriography was performed to
demonstrate patency and direction of flow in the aneurysm
side-branch arteries (lumbar, caudal mesenteric). At eutha-
nasia, selective cannulation of the side-branch arteries was
performed, and selective arteriography was carried out to
evaluate retrograde endoleak patency and to characterize
the direction of flow in the side-branch vessels and aneu-
rysm sac.
Magnetic resonance angiography (MRA) using cine se-
quences was performed before euthanasia. High-field three-
cer was attached to the luminal surface of the aneurysm.
ce of the prosthetic aneurysm.nsdudimensional magnetic resonance imaging (MRI) and electro-
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3.0-T system (GE Medical Systems, Waukesha, Wisc). Fast
cine-echo sequences were obtained at 6 weeks after the initial
creation of the aneurysm to study the patency of the reim-
planted vessels and to characterize the intra-aneurysmal
thrombus. Gadodiamide (20 mL; Amersham Health,
Buckinghamshire, UK) was injected, followed by 10 mL of
normal saline solution flush, with the injection timed to
terminate at the beginning of image acquisition. Initial
images were obtained with cardiac-gated, gradient-echo
acquisition fast-spoiled gradient-recalled acquisition proto-
col.
Histologic and pathologic analysis. The AAA, in-
cluding the side branch arteries and the stent graft, was
perfusion-fixed at 100 mm Hg in 3% glutaraldehyde buff-
ered to pH 7.4 with sodium cacodylate. The aneurysm and
side-branch vessels were removed en bloc for gross and mi-
croscopic pathologic analysis. The aneurysms were sectioned
longitudinally, and the stent graft and transducers were re-
moved. After paraffin embedding, longitudinal, transverse,
and oblique sectioning and hematoxylin and eosin staining
was performed.
Statistical analysis. All intra-aneurysmal pressure mea-
surements were indexed to the systemic pressure, which
was obtained simultaneously. All pressures are represented
as a percentage of the systemic pressure. Continuous vari-
ables were analyzed with the Student’s t test. Discrete
variables were analyzed with 2 analysis. Statistical signifi-
cance was assumed at P  .05. The Pearson correlation
coefficient was used to determine the concordance between
the sac pressures recorded by the CardioMEMS sensor and
Konigsberg transducer. A Bland and Altman difference-of-
means analysis was also performed to assess the agreement
Fig 4. Intraoperative angiogram of endovascular exclusion to
create retrograde (type II) endoleak. A, Before deployment of the
stent graft, arterial flow fills the reimplanted lumbar arteries (thick
arrow) in an antegrade fashion. The strain-gauge pressure trans-
ducer (thin arrow) can be seen exiting the aneurysm laterally. B,
After stent graft deployment, retrograde filling of the reimplanted
lumbar artery (thick arrow) is demonstrated, resulting in a type II
endoleak; (thin arrow, Konigsberg transducer).between the two pressure transducers.RESULTS
Endoleak patency and flow assessment. Aneurysm
side-branch patency and retrograde endoleak patency were
confirmed on intraoperative angiograms in all animals at
the time of the aneurysmwas excluded from antegrade flow
by stent graft deployment (Fig 4). In all animals, complete
exclusion from antegrade perfusion was achieved, and
therefore, no type I endoleaks were present. All animals
demonstrated persistent side-branch and endoleak patency
throughout the study. Retrograde endoleak patency was
confirmed with cine-MRA (Fig 5) and angiography per-
formed before euthanasia. Significant artifact was not seen
with the Konigsberg transducer, unlike the wireless pres-
sure sensor. This limited our ability to interpret signal
gradation of the intra-aneurysmal thrombus.
Intra-aneurysmal pressure. After the stent graft was
deployed and antegrade perfusion of the aneurysm was
eliminated, intra-aneurysmal pressure was significantly re-
duced to60% of systemic pressure3 hours in all animals
(P  .001; Table). The reduction in intra-aneurysmal
pressure began intraoperatively at endovascular stent graft
deployment and reached stable levels 3 hours of exclu-
sion.
After aneurysm exclusion, the average pressures mea-
Fig 5. Magnetic resonance image with gadolinium pooling
(arrow) in the excluded aneurysm sac, which indicates a patent
type II endoleak.
Type II endoleak intraaneurysmal pressure data
Systolic
pressure*
Mean
pressure*
Pulse
pressure*
Systemic pressure 1.00 1.00 1.00
AAA pressure
Strain-gauge 0.58  0.06 0.60  0.08 0.58  0.08
Wireless transducer 0.56  0.10 0.58  0.15 0.56  0.10
R 0.83 0.71 0.72
P .001 .001 .001
AAA, Abdominal aortic aneurysm.
*All pressures listed were measured after creation of the type II endoleak and
are mean pressures indexed as a percentage of the systemic pressure mea-
sured over the 4-week period.sured by the systemic Konigsberg transducer were systolic,
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77.8  9.9 mm Hg; and pulse pressure, 46.7  11.5 mm
Hg. The average intra-aneurysmal pressures recorded after
exclusion by the Konigsberg transducer were systolic, 55.4
8.1 mmHg; diastolic, 33 2.3 mmHg; mean, 41.6 2.6
mm Hg; and pulse pressure, 22  2.4 mm Hg; Those for
the CardioMEMS were systolic, 55.1  7.9 mm Hg;
diastolic, 32.6 2.1 mmHg; mean, 41 2.4 mmHg; and
pulse pressure, 21.8  2.2 mm Hg.
After the initial decline in intra-aneurysmal pressure,
pressure measurements remained stable throughout the
4-week study as recorded by both sac transducers. All
pressures listed were measured after creation of the type II
endoleak and represent average systolic, diastolic, mean,
and pulse pressures indexed as a percentage of the systemic
pressure measured over the 4-week study period (Fig 6).
The average intra-aneurysmal systolic pressure recorded
by the Konigsberg transducer after antegrade exclusion was
0.58  0.06, and was significantly lower than the average
systemic systolic pressure recorded from the native aortic
Fig 6. Tracing of the aneurysm sac pressure before (A) and after
exclusion (B) with a stent graft, simultaneously recorded by the
Konigsberg transducer (systemic and sac tracings, yellow wave-
forms) and the CardioMEMS sensor (white waveform).transducer (P  .001 vs systemic). Similarly, the averageintra-aneurysmal mean pressure after antegrade exclusion was
reduced to 0.60  0.08 and was significantly lower than the
mean systemic pressure (P  .001). The average pulse
pressure was significantly reduced (0.58  0.08) by exclu-
sion from antegrade perfusion (P .001vs systemic). Sim-
ilarly, the average systolic pressure within the aneurysm sac
recorded by the CardioMEMS wireless sensor after ante-
grade exclusion was 0.56  0.10 (P  .001vs systemic).
The average intra-aneurysmal mean pressure after ante-
grade exclusion was reduced to 0.58  0.15 (P  .001 vs
systemic). The average pulse pressure was also significantly
reduced (0.56 0.10) by exclusion from antegrade perfu-
sion (P  .001).
A close correlation was found between all pressures
recorded by both sac transducers (Table). Moreover, the
mean intra-aneurysmal pressure difference, as measured by
the Konigsberg and CardioMEMS transducers was, 0.68
1.54 mm Hg. The average sac pressures were plotted
according to the Bland and Altman analysis and showed
good agreement between the two transducers (Fig 7).
Pathologic and qualitative histologic analysis.
Gross pathologic analysis confirmed patency of the side-
branch vessels and the endoleak channel in all aneurysms.
Microscopic analysis of the lumbar and caudal mesenteric
arteries causing multiple side-branch type II endoleaks
demonstrated a widely patent lumen lined by viable endo-
thelial cells (Fig 8). Thrombus was distributed throughout
the aneurysm sac and completely surrounded the wireless
sensor and the strain-gauge transducer. The area of the
aneurysm that contained both of these transducers was
15mm distant from the source of the retrograde (type II)
endoleak, which originated from the Carrel patch with the
lumbar and caudal mesenteric arteries.
Significant variation in thrombus consistency was ob-
served within the aneurysm sac. In this region, greater
thrombus density with extensive fibrin deposition and de-
graded red blood cells was observed (Fig 9). These findings
were suggestive of stable thrombus, with deposition occur-
Fig 7. A Bland-Altman difference of means analysis was used to
determine the concordance between the sac pressures recorded by
the CardioMEMS sensor and Konigsberg transducer.ring significantly earlier. Within the aneurysm sac, the
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and limited, disorganized fibrin (1.2%). Within 5 mm from
the endoleak, the thrombus had fragments of red blood
Fig 8. Histologic cross section obtained through the aneurysm
sac at the level of the reimplanted Carrel patch demonstrates a
patent lumbar artery (hematoxylin and eosin stain; original mag-
nification 40).
Fig 9. Photomicrograph of aneurysm content demonstrates spa-
tial changes in thrombus in relation to type II endoleak. In close
proximity to retrograde endoleak and patent side branch arteries,
the intraaneurysmal thrombus consists predominately of intact red
blood cells with limited fibrin deposition. In regions of the aneu-
rysm distant from the endoleak greater thrombus organization,
with extensive fibrin deposition and degraded red blood cell frag-
ments, is present (hematoxylin and eosin, original magnification
40).cells (64.0%) and increasing fibrin deposition (5.6%). Thethrombus was made of organized fibrin (76.2%) at 5 to 10
mm from the endoleak channel, with fewer intact red blood
cells (22.1%). At distances 10 mm, the thrombus was
mostly made of fibrous tissue (87.3%) with few red blood
cells (3.6%).
This indicates that the wireless sensor functions as
accurately as the previously validated strain-gauge trans-
ducer when surrounded by dense thrombus. In contrast,
regions of the aneurysm sac that were close to the patent
side branch arteries had thrombus that contained intact red
blood cells and limited fibrin, suggestive of active remod-
eling with recent thrombus deposition.
DISCUSSION
Immediate intervention is routinely considered to cor-
rect types I and III endoleaks. Management of type II
endoleak is less clear, however. A more conservative ap-
proach to correction has been advocated becausemany type
II endoleaks, unlike type I endoleaks, undergo resolution
by spontaneous thrombosis.15 If a type II endoleak is not
sealed by 6 months after endovascular aneurysm repair
(EVAR), it is defined as a persistent endoleak, and after 12
months it is unlikely to seal spontaneously at all.16 Persis-
tent type II endoleaks require close surveillance, because
sac enlargement and rupture have been reported.17
Type II endoleak may cause pressurization of the ex-
cluded aneurysmal sac and thus influence the rate of sac
shrinkage. The in vivo study of Sonesson et al18 showed the
mean intra-aneurysmal sac pressure after EVAR to be 20% of
systolic pressure. Similarly, Baum et al19 lowered endoleak-
induced intra-aneurysmal sac pressure to30mmHg after
successful embolization of patent arterial branches.
Although no incidence of aneurysmal sac rupture oc-
curred in association with type II endoleaks in the major
aneurysm clinical trials, there are a few cases reported of
isolated type II endoleak and rupture. In addition, the
analysis of Harris et al20 of the European Collaboration on
Stent Graft Techniques for Aortic Aneurysm Repair
(EUROSTAR) data registry found nine (2.1%) AAA rup-
tures in 421 patients who had type II endoleaks at a mean
follow-up of 14.7 months; however, rupture in eight of
these patients was considered to be secondary to a concur-
rent type I endoleak. These findings have been corrobo-
rated by other clinical studies demonstrating that endoleaks
transmit systemic pulsatile pressure to the aneurysm sac
regardless of type, and that it is possible to have systemic
pressurization of the aneurysm sac without evidence of
endoleak on computed tomography (CT) scan or angiog-
raphy.19
The lack of physiologic correlation between the radio-
logic diagnosis of a type II endoleak and the degree of sac
pressurization may therefore result in unnecessary treat-
ment of benign endoleaks that would otherwise resolve
spontaneously, or potentially hazardous surveillance or un-
awareness of endoleaks that pressurize the aneurysm sac.
Current surveillance protocols after endovascular repair
include CT scans, MRI, and duplex ultrasound scanning.
The incidence of type II endoleak may vary according to
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commonly used follow-up study after EVAR, is usually
done initially before the original procedure as a baseline
measure of aneurysm dimensions and on follow-up. High
sensitivity and specificity have made this modality widely
accepted in the vascular community for surveillance of
aneurysm sac shrinkage. CT is, however, a less reliable
method for differentiating the type of endoleak. Stavropu-
los et al21 showed a sensitivity of only 81% and a specificity
of 60% in identifying the origin of a type II endoleak, with
an overall discordance between CT and conventional an-
giogram in classifying endoleaks of 33%.
These follow-up modalities, including CT scan, are
therefore sensitive only in enabling identification of sec-
ondary markers of sac pressurization, such as aneurysm sac
enlargement or perfusion. The limitation of current surveil-
lance methods is in part secondary to their inability to
measure sac pressure, which has been shown to correlate
with aneurysm growth after endovascular repair.22 The lack
of aneurysm sac pressure data in the current postoperative
surveillance protocols has been addressed by limited mea-
surement of sac pressure via direct puncture,18,19 or more
recently, by the use of implantable wireless pressure sen-
sors.12,23 The current evaluation of the CardioMEMS
wireless pressure sensor indicates correlation with readings
obtained from a strain-gauge pressure transducer. These
readings were not affected by surrounding thrombus, mak-
ing this device potentially attractive for clinical use given its
maintained accuracy in a gelatinous milieu.
Finally, although aneurysm models have been useful in
characterizing some of the complexities associated with endo-
vascular therapy, they have significant limitations. There is no
large animal model of native AAA in which the aorta under-
goes progressive aneurysmal degeneration. Current models
used to test therapeutic strategies are either prosthetic or
static and do not mimic the hemodynamics involved in
degenerative aneurysms. Moreover, current AAA models
involve healthy, nonatherosclerotic large animals. Even af-
ter balloon overstretch injury or patching, the course of the
infrarenal aorta remains essentially unchanged. It is also
important to note that significant differences exist between
the canine and human coagulation systems. As a conse-
quence of these differences, conclusions drawn from the
characterization of thrombus formation and endoleak pa-
tency in these models must be viewed with caution.
CONCLUSIONS
Despite these limitations, our results show that the
wireless implantable pressure sensor is a promising emerg-
ing technology to provide intrasac pressure measurements
that will potentially better characterize and diagnose en-
doleaks after endovascular exclusion. As shown in this
study, intra-aneurysmal pressure generated by type II en-
doleaks resulted in significant pressurization of the aneu-
rysm sac, and was accurately measured through thrombus
using the CardioMEMS wireless pressure sensor in the
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